Cough Syrup Market To Witness the Highest Growth Globally in Coming Years 2021- 2026 | being Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC

According to the latest report by IMARC Group, titled "Cough Syrup Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global cough syrup market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4% during 2021-2026.

Cough syrup is a medicated liquid consumed orally to provide relief from common cold, cough, fever and allergies. Expectorants, combination medications and cough suppressants are some commonly available variants of cough syrups. They are manufactured using eucalyptus oil, menthol, dextromethorphan (DM) and non-opioid cough suppressants. Cough syrups exhibit anti-allergic properties and consist of mucolytic agents that aid in thinning and loosening of mucus in the airways. They also ease the breath, reduce the urge to cough and clear congestion. Cough syrups are widely used by adults and children and are conveniently available over the counter.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Markets Trends and Drivers:

The global cough syrup market is primarily being driven by the rising incidence of chronic and acute respiratory diseases. Cough syrups are widely used to treat upper respiratory tract infection (URTI), asthma and other respiratory disorders. Moreover, the introduction of cough syrups with natural and organic herbs and immunity-boosting ingredients with minimal side effects is providing a thrust to the market growth. Other factors, including the rising geriatric population, along with the rapidly increasing air pollution levels, are anticipated to drive the market toward growth.

Request Free Report Sample: https://www.imarcgroup.com/cough-syrup-market/requestsample

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Competitive Landscape with Key Players:

• Acella Pharmaceuticals LLC
• Bayer AG
• GlaxoSmithKline PLC
• Johnson & Johnson
• Pfizer Inc.
• Prestige Consumer Healthcare Inc.
• Reckitt Benckiser Group PLC
• Sanofi
• Sun Pharmaceutical Industries Limited
• The Procter & Gamble Company

Key Market Segmentation:

The report has segmented the global cough syrup market on the basis of product type, age group, distribution channel and region.

Breakup by Product Type:

• Expectorants
• Cough Suppressants/Antitussives
• Combination Medications

Breakup by Age Group:

• Pediatric
• Adult

Breakup by Distribution Channel:

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/cough-syrup-market

Key Highlights of the Report:
• Market Performance (2015-2020)
• Market Outlook (2021-2026)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.